Loading clinical trials...
Loading clinical trials...
The numerical ratio between the value of the thrombin generation test performed without soluble thrombomodulin and the value of the thrombin generation test performed in the presence of soluble thrombomodulin, performed pre-surgically, could predict the risk of early venous thromboembolism after placement of total hip or knee prosthesis.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Nimes University Hospital
Nîmes, France
Start Date
February 21, 2019
Primary Completion Date
February 20, 2023
Completion Date
October 17, 2023
Last Updated
February 11, 2026
146
ACTUAL participants
Blood test
BIOLOGICAL
Doppler ultrasound
OTHER
Lead Sponsor
Centre Hospitalier Universitaire de Nīmes
NCT07102160
NCT06519435
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06451003